Regulation & Compliance

Bermuda insurer Relm adds C-suite leaders from AXIS and Zurich, signaling a strategic push to dominate insurance for AI, crypto, and space tech.

Once valued at $3.3B, the healthtech giant seeks Chapter 11 protection, a stark warning for the post-pandemic digital health industry.

National firm MNP joins forces with Vancouver's Sierra Accounting, a strategic move to capture the booming media and entertainment sector in British Columbia.

The VDR provider becomes one of only two globally to earn the new AI governance certification, raising the bar for trust in high-stakes transactions.

Death rates fall, but a new report reveals rising incidence and stark inequities. Can new drugs and AI reshape the future for all patients?

Amid rising drug price scrutiny, Red Nucleus acquires an AI-powered consultancy to revolutionize how biopharma proves the value of new medicines.

A new survey shows NFL fans are less satisfied than customers of ISPs, as high costs, officiating woes, and team losses erode the fan experience.

With a $123.9M investment and veteran bankers on its board, Varo is accelerating its mission to serve everyday Americans with tech-driven finance.

Serenity Mental Health Centers expands its ketamine therapy in Florida, offering rapid relief for depression but raising questions about cost and oversight.

As Canada observes the 30th anniversary of Black History Month, a look at its origins, the icons it honours, and its vision for the future.

The advisory giant continues its aggressive national expansion, adding a key Minneapolis firm and signaling a new competitive era for Midwest wealth management.

WTW launches a new AI platform to transform compensation strategy, promising faster, data-driven insights and a more strategic role for HR professionals.

JScreen, Manischewitz, and advocate Gila Pfeffer offer low-cost cancer and carrier genetic tests in NYC, transforming community health access.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

vTv Therapeutics shores up its finances with a deal worth up to $135M, sharpening its focus on a breakthrough Type 1 diabetes drug, cadisegliatin.

Commvault's new solution addresses rising global demand for data control, helping organizations navigate complex regulations without sacrificing cyber resilience.

Gen II Fund Services unveils its AI-powered Sensr Portal, promising to transform private market data access from static reports to conversational insights.

The RegTech firm, once a cannabis banking specialist, unveils a major rebrand and expands its platform to tackle digital assets and Money Services Businesses.

As Canadians face record debt, a new federal campaign offers free financial tools. But can online resources truly combat a national cost-of-living crisis?

Shanghai's AI EdTech innovator Jinxin faces a potential Nasdaq delisting after its stock plummets, putting its high-tech vision against market reality.